司前膏药治疗慢性软组织损伤的安全性及有效性

Analysis of safety and efficacy of Siqian plaster in treating chronic soft tissue injury

目的:探讨对慢性软组织损伤患者实施司前膏药治疗的临床效果。方法:60例慢性软组织损伤患者被随机分为对照组30例(实施常规治疗)和观察组30例(实施司前膏药治疗)。结果:治疗前两组疼痛程度VAS评分比较差异无统计学意义(P> 0. 05),经不同治疗后观察组评分低于对照组(P <0. 05),观察组总有效率高于对照组(P <0. 05),两组均未出现与治疗相关的不良反应。结论:对慢性软组织损伤患者实施司前膏药治疗效果确切,安全有效。

Objective:To explore the clinical effect of Siqian plaster on patients with chronic soft tissue injury.Methods:60cases of chronic soft tissue injury were chosen and randomly divided into the control group(treated with the conventional method)and the observation group(treated with Siqian plaster),with30cases in each group.Results:There was no significant difference in VAS scores between the two groups before treatment(P>0.05).After treatment,the score of the observation group was significantly lower than that of the control group(P<0.05).The total effective rate of the observation group was significantly higher than that of the control group(P<0.05).No treatment related adverse reactions were found in the two groups.Conclusion:Siqian plaster is safe and effective in treating chronic soft tissue injury.